Raymond James & Associates Albemarle Corp Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Albemarle Corp stock. As of the latest transaction made, Raymond James & Associates holds 83,776 shares of ALB stock, worth $9.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,776

Previous 106,753 21.52%

Holding current value

$9.08 Million

Previous $10.2 Million 22.19%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$72.85 - $100.09 $1.67 Million - $2.3 Million	-22,977 Reduced 21.52%	83,776 $7.93 Million
Q2 2024 Jul 19, 2024	SELL	$92.77 - $135.46 $2.65 Million - $3.86 Million	-28,523 Reduced 21.09%	106,753 $10.2 Million
Q1 2024 Apr 22, 2024	BUY	$108.73 - $146.89 $3.78 Million - $5.1 Million	34,724 Added 34.53%	135,276 $17.8 Million
Q4 2023 Jan 16, 2024	SELL	$113.26 - $170.8 $1.17 Million - $1.77 Million	-10,366 Reduced 9.35%	100,552 $14.5 Million
Q3 2023 Oct 24, 2023	BUY	$162.63 - $243.44 $506,267 - $757,828	3,113 Added 2.89%	110,918 $18.9 Million
Q2 2023 Jul 25, 2023	SELL	$172.91 - $232.22 $3.4 Million - $4.56 Million	-19,644 Reduced 15.41%	107,805 $24.1 Million
Q1 2023 Apr 14, 2023	BUY	$208.49 - $290.15 $1.08 Million - $1.5 Million	5,178 Added 4.23%	127,449 $28.2 Million
Q4 2022 Feb 08, 2023	BUY	$214.02 - $325.38 $2.17 Million - $3.29 Million	10,126 Added 9.03%	122,271 $26.5 Million
Q3 2022 Oct 25, 2022	BUY	$195.82 - $307.05 $4.82 Million - $7.56 Million	24,625 Added 28.14%	112,145 $29.7 Million
Q2 2022 Aug 12, 2022	BUY	$187.76 - $270.92 $750,476 - $1.08 Million	3,997 Added 4.79%	87,520 $18.3 Million
Q1 2022 May 11, 2022	SELL	$172.09 - $246.0 $4.2 Million - $6 Million	-24,393 Reduced 22.6%	83,523 $18.5 Million
Q4 2021 Feb 08, 2022	BUY	$214.16 - $283.8 $1.32 Million - $1.75 Million	6,166 Added 6.06%	107,916 $25.2 Million
Q3 2021 Nov 02, 2021	SELL	$167.91 - $244.03 $1.48 Million - $2.15 Million	-8,794 Reduced 7.96%	101,750 $22.3 Million
Q2 2021 Aug 11, 2021	BUY	$143.7 - $176.01 $1.44 Million - $1.76 Million	9,989 Added 9.93%	110,544 $18.6 Million
Q1 2021 May 14, 2021	BUY	$140.69 - $185.25 $1.97 Million - $2.59 Million	13,969 Added 16.13%	100,555 $14.7 Million
Q4 2020 Feb 12, 2021	BUY	$86.73 - $149.91 $400,692 - $692,584	4,620 Added 5.64%	86,586 $12.8 Million
Q3 2020 Nov 04, 2020	BUY	$75.75 - $100.45 $2.1 Million - $2.78 Million	27,686 Added 51.01%	81,966 $7.32 Million
Q2 2020 Jul 28, 2020	BUY	$52.7 - $86.74 $515,616 - $848,664	9,784 Added 21.99%	54,280 $4.19 Million
Q1 2020 Apr 21, 2020	SELL	$50.9 - $94.31 $743,089 - $1.38 Million	-14,599 Reduced 24.7%	44,496 $2.51 Million
Q4 2019 Feb 12, 2020	SELL	$60.74 - $73.04 $9.44 Million - $11.4 Million	-155,462 Reduced 72.46%	59,095 $4.32 Million
Q3 2019 Nov 07, 2019	BUY	$59.3 - $75.53 $3.7 Million - $4.71 Million	62,322 Added 40.94%	214,557 $14.9 Million
Q2 2019 Aug 06, 2019	BUY	$63.3 - $86.94 $4.51 Million - $6.2 Million	71,301 Added 88.1%	152,235 $10.7 Million
Q1 2019 May 06, 2019	SELL	$72.69 - $92.28 $1.88 Million - $2.39 Million	-25,874 Reduced 24.22%	80,934 $6.64 Million
Q4 2018 Feb 11, 2019	SELL	$73.13 - $107.99 $1.09 Million - $1.61 Million	-14,917 Reduced 12.25%	106,808 $8.23 Million
Q3 2018 Nov 14, 2018	BUY	$90.9 - $106.6 $4.01 Million - $4.7 Million	44,063 Added 56.74%	121,725 $12.1 Million
Q2 2018 Aug 14, 2018	BUY	$88.96 - $104.92 $779,823 - $919,728	8,766 Added 12.72%	77,662 $7.33 Million
Q1 2018 May 14, 2018	SELL	$89.56 - $137.45 $2.02 Million - $3.1 Million	-22,533 Reduced 24.65%	68,896 $6.39 Million
Q4 2017 Feb 14, 2018	SELL	$127.48 - $144.58 $997,785 - $1.13 Million	-7,827 Reduced 7.89%	91,429 $11.7 Million
Q3 2017 Nov 13, 2017	BUY	$109.36 - $136.31 $628,054 - $782,828	5,743 Added 6.14%	99,256 $13.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	93,513	93,513 $9.87 Million

Others Institutions Holding ALB

# of Institutions

928

Shares Held

104M

Call Options Held

8.36M

Put Options Held

14.3M

View Full List

About ALBEMARLE CORP

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.7B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

More about ALB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Albemarle Corp Transaction History